About Ductal Carcinoma in Situ (DCIS)

Overview

Ductal Carcinoma in Situ (DCIS) is a non-invasive breast condition where abnormal cells are found inside the breast duct but have not spread outside of it. It is also referred to as intraductal breast carcinoma or stage 0 breast carcinoma in situ. DCIS is considered a precursor to invasive breast cancer, but it is not classified as cancer because the abnormal cells have not broken through the duct wall or spread to other parts of the body. DCIS can progress to invasive breast cancer in some cases, although doctors cannot predict which cases will become invasive. Therefore, treatment is typically recommended for all cases of DCIS. Early diagnosis and appropriate treatment are crucial to prevent the development of invasive breast cancer. Screening programs have contributed to an increase in DCIS diagnoses, as most cases are detected through screening rather than presenting with symptoms.

Causes and Risk Factors

Ductal Carcinoma in Situ (DCIS) is a non-invasive form of breast cancer. The root causes of DCIS are not fully understood, but it is thought to arise from abnormal growth of cells within the milk ducts of the breast. The exact triggers for this abnormal growth are not known, but there are both non-modifiable and modifiable risk factors associated with DCIS:

Non-modifiable risk factors for DCIS cannot be changed or controlled. These include:

Family history of breast cancer: Having a close relative (such as a mother, sister, or daughter) who has had breast cancer increases the risk.
Age: The risk of DCIS increases with age, with most cases occurring in women over 50.
Genetic mutations: Certain gene mutations, such as BRCA1 and BRCA2, are associated with an increased risk of developing breast cancer.

Modifiable risk factors for DCIS can be influenced or changed. These include:

Hormone replacement therapy (HRT): Long-term use of HRT, particularly estrogen-progestin combination therapy, has been linked to an increased risk.
Obesity: Being overweight or obese increases the risk of developing DCIS.
Alcohol consumption: Regular and heavy alcohol consumption has been associated with an increased risk.

It's important to note that having one or more of these risk factors does not guarantee the development of DCIS. Regular breast screenings and early detection can greatly improve outcomes. If you have concerns about your risk factors or symptoms, consult with your healthcare professional.

Symptoms

Ductal Carcinoma in Situ (DCIS) often does not cause any obvious symptoms, and it is usually diagnosed through routine mammography screenings. However, in some cases, individuals with DCIS may experience the following symptoms:

Early stages or lower severity:

Small lumps in the breast
Discharge from the nipple

Later stages, progression, or higher severity:

Pain in the nipple or breast
Changes in the shape of the breast
Nipple discharge
Swelling of the affected breast
Thickening of nipple skin

It's important to note that many people with DCIS do not experience any symptoms and may only discover the condition when a doctor finds something during a mammogram. Regular screening mammograms can help detect potential cancers early. If you have concerns or notice any changes in your breasts, it's best to consult with your healthcare professional for further evaluation and guidance.

Diagnosis

To diagnose Ductal Carcinoma in Situ (DCIS), doctors commonly perform the following examinations, tests, and procedures:

Physical exam: A manual examination of the breasts to check for lumps or thickening.
Mammogram: An X-ray of the breasts that can detect abnormal changes in breast tissue.
Biopsy: A sample of breast tissue is taken and sent to a lab for examination to determine if it is cancerous or benign.
Ultrasound: Sound waves are used to create a detailed image of breast tissue and blood flow.
MRI: Magnetic resonance imaging can detect small lesions in the breast and is often used for high-risk individuals.

To confirm DCIS, additional examinations, tests, and procedures may be performed:

Lymph node evaluation: Lymph nodes may be examined to determine if the cancer has spread beyond the breast.
Imaging tests: Additional imaging tests like CT (computed tomography) scans or bone scans may be ordered to check for any signs of cancer.

It's important to consult with your doctor who can explain which specific tests are needed based on your individual situation.

Treatment Options

The goals of treatment for Ductal Carcinoma in Situ (DCIS) are to prevent invasive ipsilateral recurrence (stop the cancer from coming back in the same breast) and to prevent death from breast cancer. Here are the recommended treatment options and how they work to achieve these goals:

Surgical procedures:

Lumpectomy: Removes the tumor and a margin of healthy tissue around it, preserving the breast
Mastectomy: Removes the entire breast tissue

These surgeries aim to remove the DCIS cells and reduce the risk of recurrence.

Radiation therapy:

Administered after lumpectomy or mastectomy
Uses high-energy radiation to kill any remaining cancer cells
Reduces the risk of local invasive recurrence

Hormonal therapy:

Recommended for hormone receptor-positive DCIS
Involves taking medications that block or reduce estrogen levels in the body
Helps prevent hormone-driven DCIS from recurring or progressing to invasive breast cancer

Active surveillance:

For selected cases, closely monitoring the DCIS without immediate treatment
Regular mammograms and clinical exams are performed to detect any changes or progression.

It's important to note that treatment decisions depend on individual factors such as age, tumor characteristics, and personal preferences. Always consult with your healthcare professional for personalized advice.

Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Other side effects can occur. Check with your health care professional or read the information provided with your medication for additional side effect information.